Kingsley Management

Richard G. Hamermesh

Case | HBS Case Collection | June 2001 (Revised November 2004)

Kingsley Management

Abstract

Includes a brief overview of key challenges facing recent HBS graduates seeking funding for a business, followed by a 22-page excerpt from the Kingsley Management business plan. Describes Matthew Lieb and Chris Jones, two of the partners who developed the business plan for Kingsley Management, as they prepare to meet with potential investors. Lieb and Jones are particularly concerned about the investors' financial returns and the structure of the new business entity (i.e., C-corp. vs. LLC). Outlines several questions facing Lieb and his co-founders, which students are asked to resolve.

Keywords: Business Organization; Corporate Entrepreneurship; Business Plan; Opportunities; Investment Return; Organizational Structure;

Format: Print

24 pages

Educators Purchase

Citation:

Hamermesh, Richard G. "Kingsley Management." Harvard Business School Case 801-474, June 2001. (Revised November 2004.)

The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged money from the UK government for research. This in turn led to the search for a venture capital (VC) firm that could lead manage a fund, and the selection of SV Health to do that, including having Kate Bingham as a managing partner. The case describes the social and scientific needs for more dementia research, as well as the fundraising and initial team building of the fund. After the fund grows beyond the expected size, the case describes the hiring of a CEO, and asks what the next investment for the fund should be: a start-up that might soon be able to launch clinical trials, or an early-stage company with promising new research?

It is early 2018, and Emily Park, managing director of impact for the Abreu Family Office, is meeting the next day with Tomás and Maria Abreu to discuss the various ways in which the Abreus can allocate a planned $100 million to make a meaningful difference in cancer patients’ lives. Park has spent the past few months working on this project and has uncovered a multitude of options, from supporting high-performing disease-focused organizations through venture philanthropy; to investing in a fund or directly into ventures and possibly earning a good return on investment in the process; to helping address system-wide issues such as the better organization and funding of clinical trials. As she prepares to present her findings to the Abreus, she wonders which one(s) will spark their interest as the way to have the most meaningful impact, and what implications their ultimate decision will have on the Family Office in terms of its capital outlays, structure, staffing, and many other categories.

Faculty & Research

Kingsley Management

Abstract

Citation:

About the Author

More from the Author